Neuroprotective Effects of Pomegranate Juice against Parkinson’s Disease and Presence of Ellagitannins-Derived Metabolite—Urolithin A—In the Brain
Authors:
- Małgorzata KujawskaMałgorzata Kujawska
- Michael JourdesMJMichael Jourdes
- Monika KurpikMKMonika Kurpik
- Michał SzulcMichał Szulc
- Hanna SzaeferHSHanna Szaefer
- Piotr ChmielarzPCPiotr Chmielarz
- Grzegorz KreinerGKGrzegorz Kreiner
- Violetta Krajka-KuźniakVioletta Krajka-Kuźniak
- Przemyslaw Łukasz MikołajczakPrzemyslaw Łukasz Mikołajczak
- Pierre-Louis TeissedrePTPierre-Louis Teissedre
- Jadwiga Jodynis-LiebertJJJadwiga Jodynis-Liebert
Open Access
- 27 December 2019
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (1) , 202
Abstract
Pomegranate juice is a rich source of ellagitannins (ETs) believed to contribute to a wide range of pomegranate’s health benefits. While a lot of experimental studies have been devoted to Alzheimer disease and hypoxic-ischemic brain injury, our knowledge of pomegranate’s effects against Parkinson’s disease (PD) is very limited. It is suggested that its neuroprotective effects are mediated by ETs-derived metabolites—urolithins. In this study, we examined the capability of pomegranate juice for protection against PD in a rat model of parkinsonism induced by rotenone. To evaluate its efficiency, assessment of postural instability, visualization of neurodegeneration, determination of oxidative damage to lipids and α-synuclein level, as well as markers of antioxidant defense status, inflammation, and apoptosis, were performed in the midbrain. We also check the presence of plausible active pomegranate ETs-derived metabolite, urolithin A, in the plasma and brain. Our results indicated that pomegranate juice treatment provided neuroprotection as evidenced by the postural stability improvement, enhancement of neuronal survival, its protection against oxidative damage and α-synuclein aggregation, the increase in mitochondrial aldehyde dehydrogenase activity, and maintenance of antiapoptotic Bcl-xL protein at the control level. In addition, we have provided evidence for the distribution of urolithin A to the brain.Keywords
Funding Information
- Narodowe Centrum Nauki (UMO-2017/26/D/NZ7/00748)
This publication has 70 references indexed in Scilit:
- Beneficial Effect of Vitamin E in Rotenone Induced Model of PD: Behavioural, Neurochemical and Biochemical StudyExperimental Neurobiology, 2013
- Pomegranate Juice Augments Memory and fMRI Activity in Middle-Aged and Older Adults with Mild Memory ComplaintsEvidence-Based Complementary and Alternative Medicine, 2013
- Antiglycative and neuroprotective activity of colon‐derived polyphenol catabolitesMolecular Nutrition & Food Research, 2011
- Antioxidant status in rats after long‐term intake of anthocyanins and ellagitannins from blackberriesJournal of the Science of Food and Agriculture, 2010
- A highly reproducible rotenone model of Parkinson's diseaseNeurobiology of Disease, 2009
- Parkinson-Linked Genes and Toxins That Affect Neuronal Cell Death Through the Bcl-2 FamilyAntioxidants & Redox Signaling, 2009
- Pomegranate Ellagitannin-Derived Metabolites Inhibit Prostate Cancer Growth and Localize to the Mouse Prostate GlandJournal of Agricultural and Food Chemistry, 2007
- Pomegranate Polyphenols and Resveratrol Protect the Neonatal Brain against Hypoxic-Ischemic InjuryDevelopmental Neuroscience, 2007
- Standardized Hypericum perforatum reduces oxidative stress and increases gene expression of antioxidant enzymes on rotenone-exposed ratsNeuropharmacology, 2007
- Pomegranate juice decreases amyloid load and improves behavior in a mouse model of Alzheimer's diseaseNeurobiology of Disease, 2006